A Novel Promising Therapeutic Option Against Hepatitis C Virus: An Oral Nucleotide NS5B Polymerase Inhibitor Sofosbuvir

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|20|30|3733-3742

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.20, Iss.30, 2013-10, pp. : 3733-3742

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Advances in Discovery and Development of Promising Therapeutics against Hepatitis C Virus NS5B RNA-Dependent RNA Polymerase

By  

Mini Reviews in Medicinal Chemistry, Vol. 5, Iss. 12, 2005-12 ,pp. : 1103-1112

Bentham Science Publishers

Access to resources Recommend Favorite

NS5B RNA Dependent RNA Polymerase Inhibitors: The Promising Approach to Treat Hepatitis C Virus Infections

By  

Current Medicinal Chemistry, Vol. 17, Iss. 32, 2010-11 ,pp. : 3806-3826

Bentham Science Publishers

Access to resources Recommend Favorite

GS-7977: a promising nucleotide analog NS5B polymerase inhibitor of HCV

By Martel-Laferrière Valérie   Dieterich Douglas T  

Future Virology, Vol. 7, Iss. 6, 2012-06 ,pp. : 537-546

Future Medicine

Access to resources Recommend Favorite

Allosteric Inhibition of the Hepatitis C Virus NS5B RNA Dependent RNA Polymerase

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 6, Iss. 1, 2006-03 ,pp. : 31-41

Bentham Science Publishers

Access to resources Recommend Favorite

Nucleoside Inhibitors of Hepatitis C Virus NS5B Polymerase: A Systematic Review

By  

Current Drug Targets, Vol. 17, Iss. 13, 2016-09 ,pp. : 1560-1576

Bentham Science Publishers

Access to resources Recommend Favorite